Kansas City Cancer Center

Kansas City, Kansas 66112

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Non Small Cell Lung Carcinoma, Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer

Studies at this site

• First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer — Stopped early
• Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed